On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Allen Anderson: Specialized Centers Provided Additional Care Benefitting Patients
Patients diagnosed with heart failure face a variety of challenges with the condition over the course of their lifetime. As a result specialized centers can help provide the best care and help overall quality of life.
Allen Anderson from Northwestern Medicine: Treatment of Heart Failure Still Poses Challenges in Care
The diagnosis of heart failure is a common problem cardiologists face on a daily basis both in the hospital and outpatient settings. Finding the best treatments to help their quality life remains an issue being addressed across cardiology.
Tanya Simuni: Northwestern Distinguishes Itself Through Unique Approaches to Care
Located in the heart of the country Northwestern Medicine has made a name for itself in a wide range of conditions. With such a large number of specialists covering many conditions it can help provide more comprehensive care for many people locally and beyond.
Andrew Hoel: Keeping Up with the Latest Techniques in Vascular Surgery
There are constantly new innovations being developed in vascular surgery, particularly when it comes to the treatment of aneurysms and Northwestern University is one place where that work is being spearheaded.
Andrew Hoel from Northwestern Medicine: Vascular Surgeons Face Many Challenges in the Operating Room
Vascular surgery can mean operating on many parts of the body and as a result can mean surgeons face unique challenges with each procedure even as technology rapidly improves the field.
Sonal Bhatia from Pfizer: Eliquis Continues to Show Positive Results in Real World Trials
It has been several years since Eliquis was approved as an oral anticoagulant but still more research is being done to show its benefits in helping patients with non-valvular atrial fibrillation.
Jennifer Robinson: Improving Accessibility to PCSK9 Inhibitors One Year Later
It was just one year ago when doctors were excited about being able to offer PCSK9 inhibitors to patients in the hopes of helping them lower their cholesterol. Since that time one considerable challenge they have faced is overcoming the cost of this new class of medication.